Nifty
Sensex
:
:
15763.05
52586.84
-15.40 (-0.10%)
-66.23 (-0.13%)

Pharmaceuticals & Drugs - Domestic

Rating :
43/99

BSE: 531349 | NSE: PANACEABIO

320.15
30-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  327.00
  •  327.00
  •  317.35
  •  327.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  128383
  •  412.67
  •  449.00
  •  170.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,964.62
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,617.05
  • N/A
  • -53.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 9.32%
  • 15.21%
  • FII
  • DII
  • Others
  • 0.03%
  • 0.00%
  • 1.85%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.35
  • -3.59
  • -2.82

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -20.98
  • -25.59
  • -21.32

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 60.08
  • 37.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -1.14
  • -4.53
  • 9.33

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.92
  • 14.70
  • 11.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
132.45
132.76
-0.23%
168.27
125.36
34.23%
141.76
167.74
-15.49%
182.02
125.18
45.41%
Expenses
134.00
110.22
21.58%
167.33
148.23
12.89%
126.61
130.90
-3.28%
144.01
131.17
9.79%
EBITDA
-1.55
22.54
-
0.94
-22.87
-
15.15
36.84
-58.88%
38.01
-5.99
-
EBIDTM
-1.17%
16.98%
0.56%
-18.24%
10.69%
21.96%
20.88%
-4.79%
Other Income
3.23
1.19
171.43%
4.90
17.98
-72.75%
1.89
3.23
-41.49%
2.00
3.45
-42.03%
Interest
47.89
45.23
5.88%
46.91
44.46
5.51%
11.31
47.24
-76.06%
47.51
41.48
14.54%
Depreciation
11.06
11.33
-2.38%
11.58
10.05
15.22%
45.69
10.73
325.82%
11.38
11.08
2.71%
PBT
-57.27
-32.83
-
-52.65
-59.40
-
-39.96
-17.90
-
-18.88
-70.50
-
Tax
0.08
0.34
-76.47%
1.49
9.15
-83.72%
0.04
2.31
-98.27%
0.09
2.35
-96.17%
PAT
-57.35
-33.17
-
-54.14
-68.55
-
-40.00
-20.21
-
-18.97
-72.85
-
PATM
-43.30%
-24.98%
-32.17%
-54.68%
-28.22%
-12.05%
-10.42%
-58.20%
EPS
-9.36
-5.57
-
-8.83
-11.37
-
-6.53
-3.48
-
-3.15
-12.23
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
624.50
544.06
456.70
592.79
544.01
653.08
687.19
509.99
608.49
710.09
1,167.88
Net Sales Growth
13.33%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
-16.19%
-14.31%
-39.20%
 
Cost Of Goods Sold
207.82
156.79
172.24
187.25
149.52
215.81
280.21
214.00
263.41
347.57
533.58
Gross Profit
416.68
387.27
284.45
405.55
394.50
437.27
406.98
295.99
345.08
362.52
634.30
GP Margin
66.72%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
56.71%
51.05%
54.31%
Total Expenditure
571.95
518.57
589.83
508.26
496.89
541.37
643.31
592.00
694.55
796.40
899.47
Power & Fuel Cost
-
29.74
34.55
33.52
30.55
25.15
30.73
31.74
37.76
29.26
22.53
% Of Sales
-
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
6.21%
4.12%
1.93%
Employee Cost
-
144.42
147.08
151.59
148.12
142.02
135.98
144.92
146.94
160.72
143.35
% Of Sales
-
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
24.15%
22.63%
12.27%
Manufacturing Exp.
-
33.38
44.31
40.05
41.88
39.47
43.97
52.69
67.15
50.82
45.45
% Of Sales
-
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
11.04%
7.16%
3.89%
General & Admin Exp.
-
54.20
71.07
40.39
52.98
39.41
56.82
60.39
73.47
75.49
94.21
% Of Sales
-
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
11.84%
12.07%
10.63%
8.07%
Selling & Distn. Exp.
-
42.81
31.27
36.98
37.70
44.20
44.20
46.09
48.87
57.65
48.15
% Of Sales
-
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
8.03%
8.12%
4.12%
Miscellaneous Exp.
-
57.24
89.31
18.48
36.14
35.31
51.40
42.17
56.95
74.89
48.15
% Of Sales
-
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
8.27%
9.36%
10.55%
1.04%
EBITDA
52.55
25.49
-133.13
84.53
47.12
111.71
43.88
-82.01
-86.06
-86.31
268.41
EBITDA Margin
8.41%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
-14.14%
-12.15%
22.98%
Other Income
12.02
30.35
5.06
8.23
46.59
20.35
28.48
15.36
5.44
8.83
16.11
Interest
153.62
173.98
104.83
100.58
100.93
127.33
104.53
150.30
103.76
100.71
55.62
Depreciation
79.71
44.13
55.03
58.53
67.95
73.32
67.24
71.10
85.99
77.13
74.53
PBT
-168.76
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
-270.37
-255.32
154.37
Tax
1.70
16.95
8.56
9.86
-10.98
1.92
3.08
1.68
-18.76
-54.19
21.89
Tax Rate
-1.01%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
7.41%
21.22%
14.18%
PAT
-170.46
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
-234.30
-201.13
132.49
PAT before Minority Interest
-170.46
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
-234.30
-201.13
132.48
Minority Interest
0.00
0.03
0.06
2.02
1.72
2.34
1.79
1.08
0.00
0.00
0.01
PAT Margin
-27.30%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
-38.51%
-28.32%
11.34%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-27.81
-31.75
6.13
-12.10
-8.93
-3.02
-16.43
-18.20
-38.22
-32.81
21.61

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
198.79
350.40
308.68
355.68
448.61
471.29
512.72
625.69
875.12
654.03
Share Capital
6.13
6.13
6.13
6.13
22.43
22.43
6.13
6.13
6.13
6.13
Total Reserves
160.66
344.27
302.55
349.55
426.18
448.76
506.59
619.56
868.99
647.90
Non-Current Liabilities
737.40
70.08
591.13
718.78
1,100.11
918.47
767.07
865.20
720.28
502.53
Secured Loans
583.55
8.90
560.45
704.57
866.08
721.77
581.77
688.31
509.82
421.82
Unsecured Loans
29.58
37.22
10.26
9.49
1.00
1.20
1.40
1.60
2.70
1.90
Long Term Provisions
42.74
39.78
26.54
18.36
184.42
180.43
180.47
171.27
170.81
2.99
Current Liabilities
455.21
938.26
695.52
689.13
474.80
706.03
826.82
509.96
516.52
576.06
Trade Payables
198.85
269.71
277.19
248.60
187.87
209.13
252.11
175.69
122.21
97.38
Other Current Liabilities
245.38
585.25
242.00
237.52
93.60
194.85
251.91
49.82
134.72
101.62
Short Term Borrowings
3.57
69.39
164.88
190.71
191.82
295.84
320.67
274.00
249.54
363.94
Short Term Provisions
7.41
13.92
11.44
12.30
1.51
6.21
2.13
10.45
10.05
13.12
Total Liabilities
1,388.36
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52
1,733.86
Net Block
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
1,154.49
1,195.10
684.74
Gross Block
1,274.64
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
1,694.13
1,638.61
1,039.99
Accumulated Depreciation
617.25
587.34
656.87
598.70
549.18
489.18
422.09
539.64
443.51
355.25
Non Current Assets
705.08
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
1,574.45
1,617.03
920.19
Capital Work in Progress
24.01
22.51
39.92
30.41
115.78
110.31
116.55
135.26
90.83
118.90
Non Current Investment
5.58
5.33
5.25
7.01
5.19
10.20
15.97
16.51
30.91
56.58
Long Term Loans & Adv.
17.51
13.33
28.01
22.03
236.71
262.44
274.94
266.34
293.65
56.67
Other Non Current Assets
0.60
1.12
5.39
10.09
1.26
1.07
0.35
1.85
6.54
3.30
Current Assets
683.27
507.89
564.83
703.22
549.38
525.72
372.81
433.75
501.49
813.67
Current Investments
0.00
0.00
2.03
0.27
3.52
4.98
0.00
5.99
1.60
0.09
Inventories
147.69
81.43
334.21
315.55
305.24
310.22
219.81
267.94
385.26
410.63
Sundry Debtors
68.52
88.73
136.01
142.17
141.67
98.57
94.93
69.86
68.38
275.57
Cash & Bank
89.75
23.48
23.24
14.13
22.93
52.40
24.78
39.23
15.51
48.94
Other Current Assets
377.31
273.23
10.06
174.88
76.02
59.55
33.29
50.73
30.74
78.44
Short Term Loans & Adv.
41.62
41.02
59.30
56.21
66.76
50.15
24.72
44.44
19.33
70.61
Net Current Assets
228.06
-430.38
-130.69
14.08
74.58
-180.31
-454.01
-76.21
-15.03
237.61
Total Assets
1,388.35
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52
1,733.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
-30.47
104.80
118.02
130.67
90.69
37.23
53.73
-24.02
228.09
78.03
PBT
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
-253.06
-255.32
154.37
Adjustment
253.04
-70.58
166.62
149.57
148.75
167.45
59.92
161.18
200.35
71.70
Changes in Working Capital
-97.50
127.32
21.45
43.32
-58.26
-25.16
107.22
68.23
287.84
-127.30
Cash after chg. in Working capital
-21.80
102.97
121.93
125.71
71.56
42.88
56.18
-23.65
232.87
98.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-8.67
1.83
-3.91
4.96
19.13
-5.65
-2.45
-0.37
-4.78
-20.74
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-34.76
-5.27
55.29
-25.83
16.44
-37.38
-37.60
-61.19
-123.91
12.03
Net Fixed Assets
237.19
488.74
-15.06
-27.48
11.93
-29.48
-5.26
-31.39
-481.95
-30.24
Net Investments
-51.99
342.34
0.00
49.78
0.00
-0.46
-122.35
-13.38
-25.53
-7.09
Others
-219.96
-836.35
70.35
-48.13
4.51
-7.44
90.01
-16.42
383.57
49.36
Cash from Financing Activity
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
104.89
-133.63
-85.21
Net Cash Inflow / Outflow
25.51
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
19.68
-29.45
4.85
Opening Cash & Equivalents
14.47
16.44
7.47
9.59
19.97
20.84
34.95
15.16
44.26
39.58
Closing Cash & Equivalent
40.22
14.47
16.44
7.47
9.73
19.99
20.84
34.95
15.16
44.26

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
27.23
57.21
50.40
58.07
-4.43
-0.75
13.96
34.08
72.93
106.69
ROA
-14.19%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
-11.36%
-10.44%
7.47%
ROE
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
-71.43%
-36.53%
19.56%
ROCE
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
-11.89%
-10.89%
14.36%
Fixed Asset Turnover
0.41
0.30
0.37
0.35
0.40
0.41
0.30
0.37
0.53
1.16
Receivable days
52.75
89.81
85.16
92.84
67.10
51.36
58.89
41.39
88.28
59.86
Inventory Days
76.86
166.09
198.91
203.06
171.89
140.68
174.32
195.55
204.27
135.65
Payable days
178.20
213.56
186.55
163.89
130.73
137.37
148.94
82.64
57.15
38.43
Cash Conversion Cycle
-48.60
42.34
97.52
132.00
108.26
54.67
84.27
154.30
235.40
157.07
Total Debt/Equity
4.45
1.85
3.05
2.79
-100.22
93.42
12.38
4.69
1.96
1.32
Interest Cover
-0.02
1.44
0.34
0.33
0.85
0.05
0.26
-1.44
-1.54
3.78

News Update:


  • Panacea Biotec gets manufacturing license for Sputnik V vaccine
    5th Jul 2021, 09:14 AM

    The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India

    Read More
  • Panacea Biotec, Russian Direct Investment Fund launch production of Russian Sputnik V vaccine
    24th May 2021, 16:17 PM

    The first batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control

    Read More
  • Adar Poonawalla offloads entire stake in Panacea Biotec
    18th May 2021, 13:17 PM

    The shares were picked by Serum Institute of India

    Read More
  • Panacea Biotec files suit seeking to restrain Sanofi from marketing fully liquid hexavalent vaccine
    18th May 2021, 12:30 PM

    A case has been filed in order to stop infringement of its patent for fully liquid whole cell pertussis based fully liquid Hexavalent vaccine EasySix

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.